InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,579.53
(
0.12%
)
US TECH 100
19,990.00
(
0.48%
)
Dow Jones
39,192.25
(
-0.39%
)
Brent Oil
85.23
(
-0.22%
)
Bitcoin
57,574.61
(
1.55%
)
Post# of 252527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 119993
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 99985

Wednesday, 07/28/2010 11:00:36 AM

Wednesday, July 28, 2010 11:00:36 AM

Post# of 252527

The virologic-failure rate difference was higher in ECHO trial (11.0% vs 4.4%) than in THRIVE (7.1% vs 5.3%), and there's no explanation for this either.

The disparity between the VF deltas of the two trials wasn’t statsig, as far as I know. It looks like routine statistical noise.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up